{"database":"iProX","file_versions":[],"scores":null,"additional":{"omics_type":["Proteomics"],"submitter":["Xianwei Wang"],"species":["Homo Sapiens"],"full_dataset_link":["http://www.iprox.org/page/project.html?id=IPX0016598000"],"submitter_email":["Wangxianwei1116@126.com"],"submitter_affiliation":["Henan Key Laboratory of Medical Tissue Regeneration"],"sample_protocol":[""],"repository":["iProX"],"data_protocol":[""],"additional_accession":[]},"is_claimable":false,"name":"Proteomics of AC-16 cells treated with DOX","description":"Doxorubicin (DOX) is a potent chemotherapeutic agent, but its clinical use is limited by dose-dependent cardiotoxicity. To elucidate the molecular mechanisms underlying DOX-induced cardiomyopathy, we performed quantitative proteomic analysis on DOX-treated human AC-16 cardiomyocytes. The treatment group comprised AC-16 cells exposed to 0.2 µM DOX for 48 hours, with solvent-treated cells serving as the control.","dates":{"publication":"Mon Apr 13 00:00:00 BST 2026"},"accession":"PXD077062","cross_references":{"TAXONOMY":["9606"]}}